Increased small intestinal permeability during severe acute exacerbations of COPD

Roy T.M. Sprooten (Cadier en Keer, Netherlands), Roy T.M. Sprooten, I. Grimbergen, D. Braeken, K. Lenaerts, E. Rutten, E.F.M. Wouters, G.G.U. Rohde

Source: International Congress 2016 – Non-inflammatory COPD monitoring
Session: Non-inflammatory COPD monitoring
Session type: Oral Presentation
Number: 3525
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Roy T.M. Sprooten (Cadier en Keer, Netherlands), Roy T.M. Sprooten, I. Grimbergen, D. Braeken, K. Lenaerts, E. Rutten, E.F.M. Wouters, G.G.U. Rohde. Increased small intestinal permeability during severe acute exacerbations of COPD. Eur Respir J 2016; 48: Suppl. 60, 3525

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013


Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005



On relationship between local and systemic chronic inflammation and between level of hypoxia and bronchial obstruction in COPD pts
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Microparticles in stable and exacerbated COPD patients
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Insulin resistance, lung function and exacerbation rate in chronic obstructive lung disease
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016